Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

Purpose

This study explores the relationship between pre-treatment dietary patterns, fecal microbiome, and response to chemotherapy in patients with pancreatic ductal adenocarcinoma.

Conditions

  • Borderline Resectable Pancreatic Ductal Adenocarcinoma
  • Resectable Pancreatic Ductal Adenocarcinoma
  • Stage I Pancreatic Cancer AJCC v8

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • * Age ≥ 18 years with signed informed consent form - Patients must have a histological diagnosis of PDAC - Resectable or borderline resectable PDAC on imaging

Exclusion Criteria

  • * Patients with locally advanced and metastatic stage IV PDAC - Patients who have already received or completed neoadjuvant chemotherapy for PDAC - Patients with active malignancy receiving systemic therapy

Study Design

Phase
Study Type
Observational
Observational Model
Case-Only
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Observational Patients complete a dietary survey and undergo fecal sample collection on study.
  • Other: Non-Interventional Study
    Non-interventional study

Recruiting Locations

Emory University Hospital/Winship Cancer Institute
Atlanta 4180439, Georgia 4197000 30322
Contact:
Mihir M. Shah
404-778-3307
mihir.m.shah@emory.edu

More Details

NCT ID
NCT06595160
Status
Recruiting
Sponsor
Emory University

Study Contact

Mihir M. Shah, MD, FACS, FSSO
404-778-3307
mihir.m.shah@emory.edu

Detailed Description

PRIMARY OBJECTIVES: I. Evaluate the association between pre-treatment diversity of the fecal microbiome and major pathological response to neoadjuvant chemotherapy in operable pancreatic ductal adenocarcinoma patients. II. Evaluate the association between pre-treatment HEI-2015 dietary score and major pathological response to neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma patients. III. Evaluate the association between pre-treatment HEI-2015 dietary score and diversity of the fecal microbiome in pancreatic ductal adenocarcinoma patients. OUTLINE: This is an observational study. Patients complete a dietary survey and undergo fecal sample collection on study.